Skip to main content

ViaDerma, Inc. Provides an Update on its Current Marketing Efforts

Written by Customer Service on . Posted in Public Companies.

LOS ANGELES, Aug. 27, 2020 (GLOBE NEWSWIRE) — ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this update on its current marketing efforts and ongoing product trials of its topical antibiotic, Vitastem.
Vitastem, ViaDerma’s FDA registered topical antibiotic is currently being tested in some of the hospital trauma centers and ER facilities of an American national hospital chain. So far, they have reported excellent results among the patients treated with Vitastem, and are in the process of discussing the next steps with ViaDerma.Additionally, a major midwestern university and associated hospital group is actively testing the Vitastem product and is also reporting excellent results.Several marketing representatives working on behalf of ViaDerma are currently in discussions with numerous large national and international distribution networks that provide medical supplies to many large healthcare provider networks. Internationally, they are targeting healthcare providers in several regions including India, Singapore, the Middle East and South America.A meeting is planned with an international charitable medical organization to discuss the possibility of their utilizing the Vitastem product in their patient care.Dr. Christopher Otiko, President of ViaDerma, said “Our efforts are centered on getting our products into widespread use. I am very pleased with the results currently being realized in the ongoing evaluations. I have always believed that our ultimate success as a company will be due in large part to the strength of our Vitastem product.”For more information on Vitastem visit https://www.vitastem.net/About ViaDerma, Inc.
ViaDerma, Inc. (OTC: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas.Any forecast of future financial performance is a “forward looking statement” under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements.For more information, visit: www.viadermalicensing.com
Contact information:
Investor Relations
Email: info@viadermalicensing.com
Phone: 310-374-6111

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.